Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | COVID-19 | Research

Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department

Authors: Dalia Abdulhussein, Timothy E. Yap, Haider Manzar, Serge Miodragovic, Francesca Cordeiro

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Understanding public and patient attitudes to clinical research is paramount to successful recruitment. The COVID-19 pandemic has led to additional hurdles in achieving this. Our aim is to understand the current factors and attitudes towards clinical trial participation in order to assist in recruitment to clinical trials.

Methods

We conducted face-to-face interviews with patients in the outpatient department at a tertiary eye hospital facilitated by a 32-item questionnaire developed by the research team. Patient characteristics were correlated with their responses, in addition to qualitative thematic text analysis.

Results

A total of 53 patients were interviewed. Forty per cent indicated that they would be willing to participate in clinical research in the current climate. General motivating factors for involvement in research included personal gain, altruism and contribution to innovation. Factors limiting participation included concerns regarding own safety, inconvenience, accessibility and lack of benefit. 22.6% of participants felt that the COVID-19 pandemic has changed their outlook on research. These were categorised into positive (increased awareness of the importance and need for research, altruism) and negative (increased anxiety, need to minimise exposure to the hospital environment) influences.

Conclusions

Factors influencing patients’ decisions to participate in trials are similar to those observed prior to COVID-19 but with an increased focus on the environment the research is conducted in. The COVID-19 pandemic has had positive and negative impacts on patient attitudes towards research. Trial design, with a particular focus on setting and safety measures, in reassuring patients is increasingly important.
Appendix
Available only for authorised users
Literature
1.
go back to reference Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305–10.CrossRef Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305–10.CrossRef
2.
go back to reference Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20:453–8.CrossRef Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20:453–8.CrossRef
3.
go back to reference Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1987;8:6–30.CrossRef Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1987;8:6–30.CrossRef
4.
go back to reference Holden G, Rosenberg G, Barker K, Tuhrim S, Brenner B. The recruitment of research participants. Soc Work Health Care. 1993;19:1–44.CrossRef Holden G, Rosenberg G, Barker K, Tuhrim S, Brenner B. The recruitment of research participants. Soc Work Health Care. 1993;19:1–44.CrossRef
5.
go back to reference Arnetz J, et al. Preliminary development of a questionnaire measuring patient views of participation in clinical trials. BMC Res Notes. 2019;12:667.CrossRef Arnetz J, et al. Preliminary development of a questionnaire measuring patient views of participation in clinical trials. BMC Res Notes. 2019;12:667.CrossRef
6.
go back to reference Prescott RJ, et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess (Rockv). 1999;3(20):1–143. Prescott RJ, et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess (Rockv). 1999;3(20):1–143.
7.
go back to reference Schilling I, et al. Patient involvement in clinical trials: motivation and expectations differ between patients and researchers involved in a trial on urinary tract infections. Res Involv Engagem. 2019;5:15.CrossRef Schilling I, et al. Patient involvement in clinical trials: motivation and expectations differ between patients and researchers involved in a trial on urinary tract infections. Res Involv Engagem. 2019;5:15.CrossRef
8.
go back to reference van Dorn A. COVID-19 and readjusting clinical trials. Lancet (London, England). 2020;396:523–4.CrossRef van Dorn A. COVID-19 and readjusting clinical trials. Lancet (London, England). 2020;396:523–4.CrossRef
9.
go back to reference Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22:140, 55. Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22:140, 55.
10.
go back to reference Gharaibeh L, et al. Patients’ perspectives on participation in clinical trials and subsequent ethical challenges in a hospital setting in Jordan. Int J Clin Pharm. 2020;42:201–8.CrossRef Gharaibeh L, et al. Patients’ perspectives on participation in clinical trials and subsequent ethical challenges in a hospital setting in Jordan. Int J Clin Pharm. 2020;42:201–8.CrossRef
11.
go back to reference Moorcraft SY, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 2016;17:17.CrossRef Moorcraft SY, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 2016;17:17.CrossRef
12.
go back to reference Mills EJ, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006;7:141–8.CrossRef Mills EJ, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006;7:141–8.CrossRef
13.
go back to reference Comis RL, Miller JD, Aldigé CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21:830–5.CrossRef Comis RL, Miller JD, Aldigé CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21:830–5.CrossRef
14.
go back to reference Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32:35–42.CrossRef Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32:35–42.CrossRef
15.
go back to reference Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248:968–70.CrossRef Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248:968–70.CrossRef
16.
go back to reference Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patients’ point of view. Control Clin Trials. 1985;6:156–67.CrossRef Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patients’ point of view. Control Clin Trials. 1985;6:156–67.CrossRef
17.
go back to reference Verheggen FWSM, Nieman F, Jonkers R. Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial. Patient Educ Couns. 1998;35:111–25.CrossRef Verheggen FWSM, Nieman F, Jonkers R. Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial. Patient Educ Couns. 1998;35:111–25.CrossRef
18.
go back to reference Ellis PM, Butow PN, Tattersall MHN, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19:3554–61.CrossRef Ellis PM, Butow PN, Tattersall MHN, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19:3554–61.CrossRef
19.
go back to reference Kiger ME, Varpio L. Thematic analysis of qualitative data: AMEE guide no. 131. Med Teach. 2020;42(8):846–54.CrossRef Kiger ME, Varpio L. Thematic analysis of qualitative data: AMEE guide no. 131. Med Teach. 2020;42(8):846–54.CrossRef
20.
go back to reference Bevan E, Chee L, McGhee S, McInnes G. Patients’ attitudes to participation in clinical trials. Br J Clin Pharmacol. 1993;35:204–7.CrossRef Bevan E, Chee L, McGhee S, McInnes G. Patients’ attitudes to participation in clinical trials. Br J Clin Pharmacol. 1993;35:204–7.CrossRef
21.
go back to reference Sood A, et al. Patients’ attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clin Proc. 2009;84:243–7.CrossRef Sood A, et al. Patients’ attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clin Proc. 2009;84:243–7.CrossRef
22.
go back to reference Walsh E, Sheridan A. Factors affecting patient participation in clinical trials in Ireland: a narrative review. Contemp Clin Trials Commun. 2016;3:23–31.CrossRef Walsh E, Sheridan A. Factors affecting patient participation in clinical trials in Ireland: a narrative review. Contemp Clin Trials Commun. 2016;3:23–31.CrossRef
23.
go back to reference Au CPY, et al. Patient experiences in retinal trials: a cross-sectional study Retina. BMC Ophthalmol. 2015;15:80.CrossRef Au CPY, et al. Patient experiences in retinal trials: a cross-sectional study Retina. BMC Ophthalmol. 2015;15:80.CrossRef
24.
go back to reference Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol. 2000;11:939–45.CrossRef Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol. 2000;11:939–45.CrossRef
Metadata
Title
Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department
Authors
Dalia Abdulhussein
Timothy E. Yap
Haider Manzar
Serge Miodragovic
Francesca Cordeiro
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
COVID-19
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06748-1

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue